A Chemically Defined TLR3 Agonist with Anticancer Activity-Reference-Cited by-同舟云学术

A Chemically Defined TLR3 Agonist with Anticancer Activity

Published:2023-06-27 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Le Naour Julie¹²,Thierry Sylvain³,Scuderi Sarah Adriana¹²⁴,Boucard-Jourdin Mathilde³,Liu Peng¹²,Bonnin Marc³,Pan Yuhong¹²,Perret Clémence³,Zhao Liwei¹²,Mao Misha¹²,Renoux Chloé³,Pérez-Lanzón María¹²,Martin Baptiste³,Kepp Oliver¹²^ORCID,Kroemer Guido¹²⁵^ORCID,Werlé Bettina³

Affiliation:

1. Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Paris, France

2. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Villejuif, France

3. Tollys, Lyon, France

4. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy

5. Department of Biology, Institut du Cancer Paris CARPEM, Hôpital Européen Georges Pompidou, AP-HP, Paris, France

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2023.2227510

Reference38 articles.

1. Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity

2. Defining the Antigen-Specific T-Cell Response to Vaccination and Poly(I:C)/TLR3 Signaling

3. Therapeutic Efficacy of Antigen-Specific Vaccination and Toll-Like Receptor Stimulation against Established Transplanted and Autochthonous Melanoma in Mice

4. Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction

5. Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications;International Journal of Molecular Sciences;2024-05-05

2. Research Progress on the Mechanism of TLR3 Gene Mutation in the Occurrence and Development of Breast Cancer and the Clinical Characteristics and Clinical Treatment of Patients;Advances in Clinical Medicine;2024

3. Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity;International Journal of Biological Macromolecules;2023-12

4. Conventional type 1 dendritic cells (cDC1) in cancer immunity;Biology Direct;2023-11-01

5. Immunogenic cell death (ICD) enhancers—Drugs that enhance the perception of ICD by dendritic cells;Immunological Reviews;2023-08-19